Inclusion of Transgender and Gender Non-conforming Communities in Preventive HIV Vaccine Research at the HIV Vaccine Trials Network (HVTN)

Abstract

AIDS Research and Human RetrovirusesVol. 30, No. S1 Good Participatory Practices in HIV PreventionInclusion of Transgender and Gender Non-conforming Communities in Preventive HIV Vaccine Research at the HIV Vaccine Trials Network (HVTN)Gail B. Broder, Michele P. Andrasik, Shelly T. Karuna, and Transgender Working Group of the NIAID-funded HIV Vaccine Trials NetworkGail B. BroderFred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, United StatesHIV Vaccine Trials Network, Communications and Community Engagement Units, Seattle, WA, United StatesSearch for more papers by this author, Michele P. AndrasikFred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, United StatesHIV Vaccine Trials Network, Clinical Development Unit, Seattle, WA, United StatesSearch for more papers by this author, Shelly T. KarunaFred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, United StatesHIV Vaccine Trials Network, Clinical Development Unit, Seattle, WA, United StatesSearch for more papers by this author, and Transgender Working Group of the NIAID-funded HIV Vaccine Trials NetworkSearch for more papers by this authorPublished Online:30 Oct 2014https://doi.org/10.1089/aid.2014.5088.abstractAboutSectionsView articleView Full TextPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Inclusion of Transgender and Gender Non-conforming Communities in Preventive HIV Vaccine Research at the HIV Vaccine Trials Network (HVTN)." AIDS Research and Human Retroviruses, 30(S1), p. A51FiguresReferencesRelatedDetails Volume 30Issue S1Oct 2014 InformationCopyright 2014, Mary Ann Liebert, Inc.To cite this article:Gail B. Broder, Michele P. Andrasik, Shelly T. Karuna, and Transgender Working Group of the NIAID-funded HIV Vaccine Trials Network.Inclusion of Transgender and Gender Non-conforming Communities in Preventive HIV Vaccine Research at the HIV Vaccine Trials Network (HVTN).AIDS Research and Human Retroviruses.Oct 2014.A51-A51.http://doi.org/10.1089/aid.2014.5088.abstractPublished in Volume: 30 Issue S1: October 30, 2014PDF download